Skip to main content
icon for Alamar Biosciences IPO Closing Market Cap

Alamar Biosciences IPO Closing Market Cap

icon for Alamar Biosciences IPO Closing Market Cap

Alamar Biosciences IPO Closing Market Cap

1.3B+ 100.0%

<0.9B <1%

0.9B–1.0B <1%

1.0B–1.1B <1%

Polymarket

$5,969 ปริมาณ

1.3B+ 100.0%

<0.9B <1%

0.9B–1.0B <1%

1.0B–1.1B <1%

Polymarket

$5,969 ปริมาณ

<0.9B

$943 ปริมาณ

No

0.9B–1.0B

$834 ปริมาณ

No

1.0B–1.1B

$822 ปริมาณ

No

1.1B–1.2B

$741 ปริมาณ

No

1.2B–1.3B

$570 ปริมาณ

No

1.3B+

$1,621 ปริมาณ

Yes

No IPO before June 2026

$438 ปริมาณ

No

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
ปริมาณการซื้อขาย
$5,969
วันสิ้นสุด
Apr 17, 2026
ตลาดเปิดเมื่อ
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

เสนอผลลัพธ์แล้ว: No

ไม่มีการคัดค้าน

ผลลัพธ์สุดท้าย: No

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
ปริมาณการซื้อขาย
$5,969
วันสิ้นสุด
Apr 17, 2026
ตลาดเปิดเมื่อ
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

เสนอผลลัพธ์แล้ว: No

ไม่มีการคัดค้าน

ผลลัพธ์สุดท้าย: No

ระวังลิงก์ภายนอก

คำถามที่พบบ่อย

"Alamar Biosciences IPO Closing Market Cap" เป็นตลาดทำนายผลบน Polymarket ที่มี 7 ผลลัพธ์ที่เป็นไปได้ โดยนักเทรดซื้อและขายหุ้นตามสิ่งที่เชื่อว่าจะเกิดขึ้น ผลลัพธ์ที่นำอยู่ในปัจจุบันคือ "1.3B+" ที่ 100% ตามด้วย "<0.9B" ที่ 0% ราคาสะท้อนความน่าจะเป็นจากฝูงชนแบบเรียลไทม์ ตัวอย่างเช่น หุ้นที่มีราคา 100¢ หมายความว่าตลาดให้โอกาส 100% กับผลลัพธ์นั้น อัตราเหล่านี้เปลี่ยนแปลงตลอดเวลาตามที่นักเทรดตอบสนองต่อข้อมูลและพัฒนาการใหม่ หุ้นในผลลัพธ์ที่ถูกต้องสามารถแลกได้ $1 ต่อหุ้นเมื่อตลาดตัดสินผล

"Alamar Biosciences IPO Closing Market Cap" เป็นตลาดที่เพิ่งสร้างใหม่บน Polymarket เปิดเมื่อ Apr 14, 2026 ในฐานะตลาดใหม่ นี่คือโอกาสของคุณที่จะเป็นหนึ่งในนักเทรดกลุ่มแรกที่ตั้งอัตราและสร้างสัญญาณราคาเริ่มต้น คุณยังสามารถบุ๊กมาร์กหน้านี้เพื่อติดตามปริมาณและกิจกรรมการซื้อขายเมื่อตลาดเริ่มคึกคัก

ในการเทรด "Alamar Biosciences IPO Closing Market Cap" ดู 7 ผลลัพธ์ที่มีในหน้านี้ แต่ละผลลัพธ์แสดงราคาปัจจุบันที่เป็นตัวแทนความน่าจะเป็นโดยนัยของตลาด เลือกผลลัพธ์ที่คุณเชื่อว่ามีโอกาสสูงสุด เลือก "Yes" เพื่อเทรดสนับสนุนหรือ "No" เพื่อเทรดคัดค้าน ใส่จำนวนเงินแล้วกด "Trade" ถ้าผลลัพธ์ที่คุณเลือกถูกต้องเมื่อตลาดตัดสินผล หุ้น "Yes" ของคุณจ่าย $1 ต่อหุ้น ถ้าไม่ถูกต้อง จ่าย $0 คุณยังสามารถขายหุ้นได้ตลอดเวลาก่อนการตัดสินผลหากต้องการล็อกกำไรหรือตัดขาดทุน

ตัวเต็งปัจจุบันสำหรับ "Alamar Biosciences IPO Closing Market Cap" คือ "1.3B+" ที่ 100% ซึ่งหมายความว่าตลาดให้โอกาส 100% กับผลลัพธ์นั้น ผลลัพธ์ที่ตามมาคือ "<0.9B" ที่ 0% อัตราเหล่านี้อัปเดตแบบเรียลไทม์ตามที่นักเทรดซื้อและขายหุ้น จึงสะท้อนมุมมองรวมล่าสุดว่าอะไรมีโอกาสเกิดขึ้นมากที่สุด กลับมาดูบ่อยๆ หรือบุ๊กมาร์กหน้านี้เพื่อติดตามว่าอัตราเปลี่ยนไปอย่างไรเมื่อมีข้อมูลใหม่

กฎการตัดสินผลของ "Alamar Biosciences IPO Closing Market Cap" กำหนดอย่างชัดเจนว่าต้องเกิดอะไรขึ้นเพื่อให้แต่ละผลลัพธ์ถูกประกาศเป็นผู้ชนะ รวมถึงแหล่งข้อมูลอย่างเป็นทางการที่ใช้ตัดสินผล คุณสามารถตรวจสอบเกณฑ์การตัดสินผลทั้งหมดได้ในส่วน "กฎ" บนหน้านี้เหนือความคิดเห็น เราแนะนำให้อ่านกฎอย่างละเอียดก่อนเทรด เพราะกฎระบุเงื่อนไขเฉพาะ กรณีพิเศษ และแหล่งข้อมูลที่ควบคุมการตัดสินตลาดนี้